KVUE Kenvue Inc.

NYSE www.jnj.com/kenvue/


$ 16.20 $ -0.04 (-0.25 %)    

Tuesday, 04-Nov-2025 12:33:20 EST
QQQ $ 622.28 $ -0.97 (-0.16 %)
DIA $ 471.08 $ 0.72 (0.15 %)
SPY $ 676.70 $ 0.59 (0.09 %)
TLT $ 89.97 $ 0.17 (0.19 %)
GLD $ 364.51 $ 0.91 (0.25 %)
$ 16.14
$ 16.23
$ 16.19 x 1,400
$ 16.20 x 905
$ 15.97 - $ 16.42
$ 14.02 - $ 24.72
203,525,996
na
30.92B
$ 0.90
$ 21.58
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-03-2025 09-28-2025 10-Q
2 08-07-2025 06-29-2025 10-Q
3 05-08-2025 03-30-2025 10-Q
4 02-24-2025 12-29-2024 10-K
5 11-07-2024 09-29-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-01-2024 12-31-2023 10-K
9 11-03-2023 10-01-2023 10-Q
10 08-02-2023 07-02-2023 10-Q
11 06-02-2023 04-02-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 options-corner-kimberly-clarks-implosion-offers-an-unusual-informational-arbitrage-opportunity

Although Kimberly-Clark suffered a huge blow after announcing its Kenvue buyout, KMB stock is flashing a quantitative contraria...

 nvidia-amazon-extend-rally-bitcoin-sinks-to-107000-whats-moving-markets-monday

Wall Street opened the week on a mixed note on Monday.

Core News & Articles

Buffett Sells Stocks

Core News & Articles

https://www.wsj.com/business/deals/activist-investors-in-kenvue-faced-big-losses-kimberly-clark-saved-the-day-df6bb04a

 kenvue-affirms-fy2025-adj-eps-guidance-of-100-105-vs-104-est

Kenvue (NYSE:KVUE) affirms FY2025 Adj EPS guidance from $1.00-$1.05 to $1.00-$1.05 vs $1.04 analyst estimate..

 kimberly-clark-stock-plunges-over-16-kenvue-surges-20-in-monday-pre-market-whats-going-on

Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it ann...

 kenvue-q3-adj-eps-028-beats-027-estimate-sales-3764b-miss-3836b-estimate

Kenvue (NYSE:KVUE) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.27 by 5.66 pe...

Core News & Articles

Combines Highly Complementary and Strategically Aligned Consumer Offerings, Including 10 Iconic Billion-Dollar Brands, That Wil...

 hhs-kennedy-on-tylenol-says-not-enough-evidence-to-show-tylenol-definitively-causes-autism-but-some-studies-seem-very-suggestive

https://x.com/US_FDA/status/1983585600214061232

 canaccord-genuity-downgrades-kenvue-to-hold-lowers-price-target-to-15

Canaccord Genuity analyst Susan Anderson downgrades Kenvue (NYSE:KVUE) from Buy to Hold and lowers the price target from $26...

 ken-paxton-alleges-johnson--johnson-misled-mothers-on-tylenol-safety

Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for ...

Core News & Articles

https://www.texasattorneygeneral.gov/news/releases/attorney-general-paxton-sues-big-pharma-manufacturers-deceptively-marketing-...

 jefferies-maintains-buy-on-kenvue-lowers-price-target-to-23

Jefferies analyst Keith Devas maintains Kenvue (NYSE:KVUE) with a Buy and lowers the price target from $25 to $23.

 president-trump-earlier-sunday-in-truth-social-post-pregnant-women-dont-use-tylenol-unless-absolutely-necessary-dont-give-tylenol-to-your-young-child-for-virtually-any-reason

https://truthsocial.com/@realDonaldTrump/115442316583935494

 starboard-ceo-jeff-smith-on-kenvue-ceo-says-there-is-a-search-underway-for-a-new-ceo

-CNBC Interview

 kenvue-urges-fda-to-reject-request-for-autism-warning-on-tylenol--bloomberg

https://www.bloomberg.com/news/articles/2025-10-20/tylenol-autism-warning-should-be-rejected-kenvue-tells-us-regulators?embedde...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION